TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) - Related Studies

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) (TTEDD)

This study is currently recruiting participants.

Study NCT00451321. Last updated on September 26, 2008. Information provided by Tolerx Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Type 1 Diabetes Mellitus

2	Additional conditions recognized in this trial
		Diabetes Mellitus
		Diabetes Mellitus, Type 1

3	More general conditions related to this trial
		Autoimmune Diseases
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Immune System Diseases
		Metabolic Diseases

4	Interventions listed in this trial
		TRX4 monoclonal antibody

5	Additional drug interventions recognized in this trial
		Antibodies
		Antibodies, Monoclonal

6	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Tolerx Inc.
		Juvenile Diabetes Research Foundation (JDRF)